本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

77.51
-0.1900-0.24%
盤後77.510.00000.00%19:53 EDT
成交量:91.78萬
成交額:7,095.87萬
市值:150.26億
市盈率:-20.51
高:78.45
開:77.21
低:76.28
收:77.70
52周最高:84.94
52周最低:31.77
股本:1.94億
流通股本:1.51億
量比:0.46
換手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-3.7800
每股收益(LYR):-3.7850
淨資產收益率:-1789.67%
總資產收益率:-33.83%
市淨率:-7.20
市盈率(LYR):-20.48

資料載入中...

2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

重要事件披露

8-K - Current report
2021/01/26

重要事件披露

8-K - Current report
2021/01/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

重要事件披露

8-K - Current report
2021/01/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/20

重要事件披露

8-K - Current report
2021/01/13

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/12

重要事件披露

8-K - Current report
2021/01/12

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/04

企業合併公告

425 - Prospectuses and communications, business combinations